The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Antipsychotic Drug Use and Mortality in Older Adults with Dementia
Abstract
BACKGROUND: Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety. OBJECTIVE: To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality. DESIGN: Population-based, retrospective cohort study. SETTING: Ontario, Canada. PATIENTS: Older adults with dementia who were followed between 1 April 1997 and 31 March 2003. MEASUREMENTS: The risk for death was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. Two pairwise comparisons were made: atypical versus no antipsychotic use and conventional versus atypical antipsychotic use. Groups were stratified by place of residence (community or long-term care). Propensity score matching was used to adjust for differences in baseline health status. RESULTS: A total of 27,259 matched pairs were identified. New use of atypical antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse in both the community-dwelling cohort (adjusted hazard ratio, 1.31 [95% CI, 1.02 to 1.70]; absolute risk difference, 0.2 percentage point) and the long-term care cohort (adjusted hazard ratio, 1.55 [CI, 1.15 to 2.07]; absolute risk difference, 1.2 percentage points). Excess risk seemed to persist to 180 days, but unequal rates of censoring over time may have affected these results. Relative to atypical antipsychotic use, conventional antipsychotic use was associated with a higher risk for death at all time points. Sensitivity analysis revealed that unmeasured confounders that increase the risk for death could diminish or eliminate the observed associations. LIMITATIONS: Information on causes of death was not available. Many patients did not continue their initial treatments after 1 month of therapy. Unmeasured confounders could affect associations. CONCLUSIONS: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A similar black box warning for conventional antipsychotics, based on two observational studies that showed increased risk of mortality in older adults using conventional versus atypical antipsychotics, was announced in 2008.117 118 119”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, it announced a black box warning for the use of atypical antipsychotics for behavioral and psychological symptoms of dementia.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 2005, the FDA announced that, based on a re-analysis of 17 placebo controlled trials (several of which were unpublished), atypical antipsychotics were associated with a 1.7-fold increase in mortality compared with placebo.117 118”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A meta-analysis found an odds ratio for mortality with these drugs of 1.54 (1.06 to 2.23; Z=2.28; P=0.02), with pooled events of 3.5% mortality for the drug versus 2.3% for placebo.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have shown that nonpharmacological treatments pose fewer side effects, which render them as safer options [20].”
From Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review (2015) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Rosenbaum, P. R., & Rubin, D. B. (1985) · The American Statistician · doi:10.2307/2683903 · Cited by 6,472
Variable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., Lebowitz, B. D., Lyketsos, C. G., Ryan, J. M., Stroup, T. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061240 · Cited by 1,206
Austin, P. C., Grootendorst, P. V., & Anderson, G. M. (2006) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,138
Self-citationRisk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Effectiveness of Collaborative Care for Older Adults With Alzheimer Disease in Primary Care
Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., Fultz, B. A., Hui, S. L., Counsell, S. R., & Hendrie, H. C. (2006) · JAMA · doi:10.1001/jama.295.18.2148 · Cited by 799
Schneeweiß, S. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1200 · Cited by 741
A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
Schneider, L. S., Pollock, V. E., & Lyness, S. A. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb02407.x · Cited by 650
Livingston, G., Johnston, K., Katona, C., Paton, J., Lyketsos, C. G., & Old Age Task Force of the World Federation of Biological Psychiatry (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.1996 · Cited by 591 · cited 1×
“Nonpharmacologic treatments for neuropsychiatric symptoms of dementia have been reviewed (62).”
BackgroundFossey, J., Ballard, C. G., Juszczak, E., James, I. A., Alder, N. C., Jacoby, R. J., & Howard, R. J. (2006) · BMJ · doi:10.1136/bmj.38782.575868.7c · Cited by 511
(2003) · PubMed · Cited by 490
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S. K., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 437
The incidence of adverse drug events in two large academic long-term care facilities
Gurwitz, J. H., Field, T. S., Judge, J. O., Rochon, P. A., Harrold, L. R., Cadoret, C. A., Lee, M. M., White, K., LaPrino, J., Erramuspe‐Mainard, J., et al. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.09.018 · Cited by 403
Self-citationGill, S. S., Rochon, P. A., Herrmann, N., Lee, P. E., Sykora, K., Gunraj, N., Normand, S.-L. T., Gurwitz, J. H., Marras, C., Wodchis, W. P., et al. (2005) · BMJ · doi:10.1136/bmj.38330.470486.8f · Cited by 402
Self-citationSchizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395
Tiihonen, J., Wahlbeck, K., Lönnqvist, J. K., Klaukka, T., Ioannidis, J. P. A., Volavka, J., & Haukka, J. K. (2006) · BMJ · doi:10.1136/bmj.38881.382755.2f · Cited by 389
Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease
Scarmeas, N., Brandt, J., Albert, M., Hadjigeorgiou, G. M., Papadimitriou, A., Dubois, B., Sarazin, M., Devanand, D. P., Honig, L. S., Marder, K. S., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1601 · Cited by 350
Zornberg, G. L., & Jick, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02784-7 · Cited by 269
Antipsychotics and the Risk of Sudden Cardiac Death
Straus, S. M. J. M., Bleumink, G. S., Dieleman, J. P., van der Lei, J., Jong, G. W. ‘., Kingma, J. H., Sturkenboom, M., & Stricker, B. H. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1293 · Cited by 262
Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death
Straus, S. M. J. M., Sturkenboom, M., Bleumink, G. S., Dieleman, J. P., van der Lei, J., de Graeff, P. A., Kingma, J. H., & Stricker, B. H. C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi312 · Cited by 259
Behavioural changes and psychological symptoms in dementia disorders
McKeith, I. G., & Cummings, J. L. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70219-2 · Cited by 234
Lee, P. E., Gill, S. S., Freedman, M., Bronskill, S. E., Hillmer, M. P., & Rochon, P. A. (2004) · BMJ · doi:10.1136/bmj.38125.465579.55 · Cited by 225
Self-citationFahey, T. P., Montgomery, A. A., Barnes, J., & Protheroe, J. (2003) · BMJ · doi:10.1136/bmj.326.7389.580 · Cited by 199
Liperoti, R., Pedone, C., Lapane, K. L., Mor, V., Bernabei, R., & Gambassi, G. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2677 · Cited by 172
Normand, S. T., Sykora, K., Li, P., Mamdani, M., Rochon, P. A., & Anderson, G. (2005) · BMJ · doi:10.1136/bmj.330.7498.1021 · Cited by 169
Self-citationReducing Antipsychotic Drug Use in Nursing Homes
Ray, W. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410060023005 · Cited by 160
Dementia: The leading predictor of death in a defined elderly population
Tschanz, J. T., Corcoran, C. M., Skoog, I. G., Khachaturian, A. S., Herrick, J. S., Hayden, K. M., Welsh-Bohmer, K. A., Calvert, T., Norton, M. C., Zandi, P. P., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000118210.12660.c2 · Cited by 154
Ballard, C. G., Thomas, A. J., Fossey, J., Lee, L., Jacoby, R. J., Lana, M. M., Bannister, C., McShane, R. H., Swann, A., Juszczak, E., et al. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0120 · Cited by 141
Efficacy and Safety of Neuroleptics in Behavioral Disorders Associated With Dementia
Lanctôt, K. L., Best, T. S., Mittmann, N., Liu, B. A., OH, P. I., Einarson, T. R., & Naranjo, C. A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1010 · Cited by 136
Liperoti, R., Gambassi, G., Lapane, K. L., Chiang, C., Pedone, C., Mor, V., & Bernabei, R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.6.696 · Cited by 136
Liperoti, R., Gambassi, G., Lapane, K. L., Chiang, C., Pedone, C., Mor, V., & Bernabei, R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0901 · Cited by 108
Association between Screening for Osteoporosis and the Incidence of Hip Fracture
Kern, L. M., Powe, N. R., Levine, M. A., Fitzpatrick, A. L., Harris, T. B., Robbins, J. A., & Fried, L. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-3-200502010-00007 · Cited by 105
Keene, J., Hope, T., Fairburn, C. G., & Jacoby, R. J. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.474 · Cited by 97
Bronskill, S. E., Anderson, G., Sykora, K., Wodchis, W. P., Gill, S. S., Shulman, K. I., & Rochon, P. A. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52212.x · Cited by 95
Self-citationThe Use of Atypical Antipsychotics in Nursing Homes
Liperoti, R., Mor, V., Lapane, K. L., Pedone, C., Gambassi, G., & Bernabei, R. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0918 · Cited by 90
Effects of Antipsychotic Withdrawal in Elderly Nursing Home Residents
Thapa, P. B., Meador, K. G., Gideon, P. S., Fought, R. L., & Ray, W. A. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb01752.x · Cited by 79
Antipsychotic use in the elderly: shifting trends and increasing costs
Rapoport, M. J., Mamdani, M., Shulman, K. I., Herrmann, N., & Rochon, P. A. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1358 · Cited by 75
Self-citationvan Reekum, R., Conn, D. K., Clarke, D. E., Cohen, T., Ostrander, L., Herrmann, N., & Eryavec, G. M. (2002) · International Psychogeriatrics · doi:10.1017/s1041610202008396 · Cited by 74
Self-citationAll‐cause mortality associated with atypical and typical antipsychotics in demented outpatients
Trifirò, G., Verhamme, K. M. C., Ziere, G. J., Caputi, A. P., Stricker, B. H. C., & Sturkenboom, M. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1334 · Cited by 73
Meador, K. G., Taylor, J. A., Thapa, P. B., Fought, R. L., & Ray, W. A. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb04509.x · Cited by 64
Nasrallah, H. A., White, T., & Nasrallah, A. T. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200407000-00012 · Cited by 63
Choking deaths: the role of antipsychotic medication
Ruschena, D., Mullen, P. E., Palmer, S., Burgess, P. M., Cordner, S. M., Drummer, O. H., Wallace, C., & Barry-Walsh, J. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.5.446 · Cited by 60
Observational Studies of Drugs and Mortality
Ray, W. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058267 · Cited by 58
Suh, G., & Shah, A. K. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205002243 · Cited by 55
Foreign body asphyxiation—an autopsy study
Berzlanovich, A. M., Muhm, M., Sim, E., & Bauer, G. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00242-9 · Cited by 51
Livingston, G., Walker, A. E., Katona, C., & Cooper, C. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.094342 · Cited by 51
Vickrey, B. G., Mittman, B. S., Connor, K. I., Pearson, M. L., Della Penna, R. D., Ganiats, T. G., DeMonte, R. W., Chodosh, J., Cui, X., Vassar, S., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00004 · Cited by 44
Barnett, M. J., Perry, P. J., ALEXANDER, B. K., & Kaboli, P. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203598.43314.34 · Cited by 41
Kryzhanovskaya, L. A., Jeste, D. V., Young, C. A., Polzer, J. P., Roddy, T. E., Jansen, J. F., Carlson, J. L., & Cavazzoni, P. A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0610 · Cited by 41
Antipsychotic Drugs in Dementia
Rabins, P. V., & Lyketsos, C. G. (2005) · JAMA · doi:10.1001/jama.294.15.1963 · Cited by 38
Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh?
Ballard, C. G., & Cream, J. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205221026 · Cited by 38
Ballard, C. G., & Margallo‐Lana, M. (2004) · PubMed · Cited by 37
Envisioning Better Approaches for Dementia Care
Covinsky, K. E., & Johnston, C. B. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00011 · Cited by 25
Antipsychotics and sudden death: Is thioridazine the only bad actor?
Ray, W. A., & Meador, K. G. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.6.483 · Cited by 24
Belle, S. H., Burgio, L., Burns, R., Coon, D., Czaja, S. J., Gallagher-Thompson, D., Gitlin, L. N., Klinger, J., Koepke, K. M., Lee, C. C., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00005 · Cited by 23
Shah, A., & Suh, G. H. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205231022 · Cited by 16
Comparative cardiac safety of low‐dose thioridazine and low‐dose haloperidol
Hennessy, S., Bilker, W. B., KNAUSS, J. S., Kimmel, S. E., Margolis, D. J., Morrison, M. F., Reynolds, R. F., Glasser, D. B., & Strom, B. L. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02098.x · Cited by 15
Risk of choking in mental illness
Warner, J. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15664-x · Cited by 12
Atypical Antipsychotic Drugs, Dementia, and Risk of Death
Sikand, H., Jaojoco, J., Linares, L., & Phillips, P. S. (2006) · JAMA · doi:10.1001/jama.295.5.495-b · Cited by 10
D’Agostino (1998) · doi:10.1002/(sici)1097-0258(19981015)17:19
Research works printed but not linked: 4
- Levy AR, 2003, Can J Clin Pharmacol, 10, 67
- 10.1080/00031305.1985.10479383 · DOI
- Trifirò G, 2006, Pharmacoepidemiol Drug Saf
- Gill SS, 2006, JAMA, 295, 495
Cited by
Sorted by citations
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“An increased mortality risk has been associated with the use antipsychotics in older patients with dementia [1377-1379], which appears to be greater with conventional compared to atypical antipsychotics [1378-1380].”
BackgroundTreatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
Cummings, J. L., Tong, G., & Ballard, C. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180766 · Cited by 588
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 584
Maher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J.-H., Ewing, B., Wang, Z., Timmer, M., Sultzer, D., & Shekelle, P. G. (2011) · JAMA · doi:10.1001/jama.2011.1360 · Cited by 558
Metadata
- Authors
- Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., Gurwitz, J. H., & Rochon, P. A.
- Affiliations
- Harvard University (US)
- From Queen's University, Kingston, Ontario, Canada; Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Ontario, Canada; Harvard Medical School and Harvard School of Public Health, Boston, Massachusetts; University of British Columbia, Vancouver, British Columbia, Canada; and Meyers Primary Care Institute of the University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, Massachusetts.
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-06-05
- Volume
- 146
- Issue
- 11
- Pages
- 775-786
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2144855317
- Cited by
- 624
- References
- 66
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 22 · 2022: 30 · 2021: 18 · 2020: 27 · 2019: 31 · 2018: 38 · 2017: 36 · 2016: 45 · 2015: 42 · 2014: 30 · 2013: 37 · 2012: 35
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- antipsychotic drugs, atypical antipsychotics, typical antipsychotics, dementia, all-cause mortality, older adults, behavioral and psychological symptoms of dementia, long-term care, community-dwelling older adults, drug safety
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Humans, Male, Ontario, Sensitivity and Specificity, Time Factors, Antipsychotic Agents, Matched-Pair Analysis, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
